SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-12-000601
Filing Date
2012-08-07
Accepted
2012-08-07 17:05:14
Documents
10
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR THE PERIOD ENDED 6/30/2012 appy_10q-063012.htm 10-Q 643935
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 14078
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 14219
4 EXHIBIT 32 ex32.htm EX-32 11462
  Complete submission text file 0001079973-12-000601.txt   5187565

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT appy-20120630.xml EX-101.INS 747622
6 XBRL TAXONOMY EXTENSION SCHEMA appy-20120630.xsd EX-101.SCH 56418
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE appy-20120630_cal.xml EX-101.CAL 31204
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE appy-20120630_def.xml EX-101.DEF 190310
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE appy-20120630_lab.xml EX-101.LAB 614124
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE appy-20120630_pre.xml EX-101.PRE 269717
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Filer) CIK: 0001167419 (see all company filings)

IRS No.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33675 | Film No.: 121014146
SIC: 2835 In Vitro & In Vivo Diagnostic Substances